0001922565-22-000001.txt : 20220415 0001922565-22-000001.hdr.sgml : 20220415 20220414181334 ACCESSION NUMBER: 0001922565-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220415 DATE AS OF CHANGE: 20220414 EFFECTIVENESS DATE: 20220415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DNAlite Therapeutics, Inc. CENTRAL INDEX KEY: 0001922565 IRS NUMBER: 811554862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-441983 FILM NUMBER: 22828585 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (713) 569-0302 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001922565 DNAlite Therapeutics, Inc. 455 MISSION BAY BOULEVARD SAN FRANCISCO CA CALIFORNIA 94158 (713) 569-0302 DELAWARE None None Corporation true Mubhij Ahmad 455 Mission Bay Boulevard San Francisco CA CALIFORNIA 94158 Executive Officer Director Timothy Paul Day 455 Mission Bay Boulevard San Francisco CA CALIFORNIA 94158 Director Andrew Cain McClary 455 Mission Bay Boulevard San Francisco CA CALIFORNIA 94158 Director Drew Lanza 455 Mission Bay Boulevard San Francisco CA CALIFORNIA 94158 Director David Rabuka 455 Mission Bay Boulevard San Francisco CA CALIFORNIA 94158 Director Biotechnology Decline to Disclose 06b false 2022-04-01 false true false 0 8929986 5596650 3333336 false 18 0 0 0 false DNAlite Therapeutics, Inc. /s/ Mubhij Ahmad Mubhij Ahmad Chief Executive Officer 2022-04-14